INKON Life stated during an institutional research on January 7 that the company is actively exploring AI + clinical innovation applications to empower diagnostic and treatment services. Currently, AI devices and systems have been gradually implemented in the hospitals under the company, covering eight major scenarios: 3D visualization scenario, imaging diagnosis scenario, case generation scenario, radiation therapy scenario, intelligent follow-up scenario, intelligent guidance scenario, intelligent decision support scenario, and intrinsic quality control scenario, helping to enhance the hospital's diagnostic capabilities, experience levels, and operational efficiency; in terms of diagnostic capabilities, the dual reading of images by AI + doctors has improved the detection rate of pulmonary nodules by 32%; in terms of experience levels, 3D reconstruction makes treatment visualized, facilitating communication between doctors and patients as well as surgical simulation. In the future, INKON Life will continue to explore innovative applications of AI technology in clinical and device fields, continuously increase investment in the healthcare sector, and build intrinsic core competitiveness, accelerating the layout and development of the entire industry chain for tumor pre-diagnosis/treatment/recovery